388 related articles for article (PubMed ID: 23920041)
1. DYRK1A overexpression decreases plasma lecithin:cholesterol acyltransferase activity and apolipoprotein A-I levels.
Tlili A; Noll C; Middendorp S; Duchon A; Jouan M; Benabou E; Hérault Y; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2013 Nov; 110(3):371-7. PubMed ID: 23920041
[TBL] [Abstract][Full Text] [Related]
2. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
3. Dyrk1a activates antioxidant NQO1 expression through an ERK1/2-Nrf2 dependent mechanism.
Noll C; Tlili A; Ripoll C; Mallet L; Paul JL; Delabar JM; Janel N
Mol Genet Metab; 2012 Mar; 105(3):484-8. PubMed ID: 22178546
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome.
Hijazi M; Fillat C; Medina JM; Velasco A
Exp Neurol; 2013 Jan; 239():229-34. PubMed ID: 23124096
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
[TBL] [Abstract][Full Text] [Related]
7. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
[TBL] [Abstract][Full Text] [Related]
8. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein cholesterol subfractions and lecithin: cholesterol acyltransferase activity in collegiate soccer players.
Imamura H; Nagata A; Oshikata R; Yoshimura Y; Miyamoto N; Miyahara K; Oda K; Iide K
Int J Sports Med; 2013 May; 34(5):398-401. PubMed ID: 23152129
[TBL] [Abstract][Full Text] [Related]
10. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease).
Pritchard PH; McLeod R; Frohlich J; Park MC; Kudchodkar BJ; Lacko AG
Biochim Biophys Acta; 1988 Feb; 958(2):227-34. PubMed ID: 3122840
[TBL] [Abstract][Full Text] [Related]
11. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
[TBL] [Abstract][Full Text] [Related]
12. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
De la Torre R; De Sola S; Pons M; Duchon A; de Lagran MM; Farré M; Fitó M; Benejam B; Langohr K; Rodriguez J; Pujadas M; Bizot JC; Cuenca A; Janel N; Catuara S; Covas MI; Blehaut H; Herault Y; Delabar JM; Dierssen M
Mol Nutr Food Res; 2014 Feb; 58(2):278-88. PubMed ID: 24039182
[TBL] [Abstract][Full Text] [Related]
15. Relationship of high density lipoprotein composition to plasma lecithin:cholesterol acyltransferase concentration in men.
Miller NE; Rajput-Williams J; Nanjee MN; Samuel L; Albers JJ
Atherosclerosis; 1988 Feb; 69(2-3):123-9. PubMed ID: 3126747
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
[TBL] [Abstract][Full Text] [Related]
17. Interspecies activation of lecithin-cholesterol acyltransferase by apolipoprotein A-I isolated from the plasma of humans, horses, sheep, goats and rabbits.
Chen CH; Albers JJ
Biochim Biophys Acta; 1983 Aug; 753(1):40-6. PubMed ID: 6411128
[TBL] [Abstract][Full Text] [Related]
18. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.
Hoeg JM; Vaisman BL; Demosky SJ; Meyn SM; Talley GD; Hoyt RF; Feldman S; Bérard AM; Sakai N; Wood D; Brousseau ME; Marcovina S; Brewer HB; Santamarina-Fojo S
J Biol Chem; 1996 Feb; 271(8):4396-402. PubMed ID: 8626790
[TBL] [Abstract][Full Text] [Related]
19. Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters.
Chen Z; Wang SP; Krsmanovic ML; Castro-Perez J; Gagen K; Mendoza V; Rosa R; Shah V; He T; Stout SJ; Geoghagen NS; Lee SH; McLaren DG; Wang L; Roddy TP; Plump AS; Hubbard BK; Sinz CJ; Johns DG
Metabolism; 2012 Apr; 61(4):470-81. PubMed ID: 22001333
[TBL] [Abstract][Full Text] [Related]
20. DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
Kariyawasam D; Rachdi L; Carré A; Martin M; Houlier M; Janel N; Delabar JM; Scharfmann R; Polak M
Endocrinology; 2015 Mar; 156(3):1171-80. PubMed ID: 25490145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
